We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Surveillance for West Nile Virus in Overwintering Mosquitoes—New York, 2000 FREE

JAMA. 2000;283(18):2380-2381. doi:10.1001/jama.283.18.2380.
Text Size: A A A
Published online

MMWR. 2000;49:178-179

Following the 1999 West Nile encephalitis outbreak in New York, guidelines were developed to direct surveillance, prevention, and control efforts in the eastern United States.1 As recommended in the guidelines, the New York City and New York state departments of health developed comprehensive West Nile virus (WNV) surveillance and control programs, which included collecting overwintering Culex mosquitoes to determine whether WNV might persist throughout the winter and initiate a zoonotic transmission cycle in the spring of 2000. As part of this surveillance effort, adult Culex mosquitoes were collected from structures in New York City during January-February 2000 to determine whether overwintering mosquitoes were infected with WNV. This report summarizes the results of this analysis, which documented WNV RNA in some mosquito pools.

Mosquitoes were sought from sites within the city's storm and sanitary sewer system, historic sites at Fort Totten in northeastern Queens, hangars and other locations at the abandoned Flushing Airport, and utility rooms under the Whitestone Bridge and under municipal swimming pools. Collection sites were selected based on location of WNV-infected humans and mosquitoes during the 1999 outbreak.2 Mosquitoes were pooled and then tested for the presence of WNV using vero cell plaque assay3 and a fluorogenic real-time polymerase chain reaction (PCR) assay (TaqMan, Perkin-Elmer Biosystems, Foster City, California*) that focused on three different primer pairs: the envelope protein and the N-1 and NS-5 regions.4

No pools produced live virus isolates in the plaque assay. However, three of the 67 pools containing Culex spp. mosquitoes, all of which were collected from Fort Totten, reproducibly demonstrated low but detectable levels of WNV RNA.


J Cooper, MPA, New York City Dept of Parks and Recreation; J Miller, MD, New York City Dept of Health; P Bennett, MPH, New York City Dept of Environmental Protection; D White, PhD, P Smith, State Epidemiologist, New York State Dept of Health. Arbovirus Diseases Br, Div of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, CDC.


The standard technique for detecting virus in mosquitoes is the cell culture plaque assay, which detects only live virus. The real-time PCR technique was first used to detect WNV RNA in mosquitoes in the outbreak investigation during September-November 1999, and produced results consistent with those obtained by plaque assay (CDC, unpublished data, 1999). This experimental assay is highly sensitive for detecting the nucleic acids of pathogens and represents a novel approach for detecting and quantifying viruses.

In the positive pools described in this report, the intensity of the TaqMan signal was in the range consistent with approximately one plaque forming unit (vero cell plaque assay equivalent) according to a standard curve generated in the assay. The ability to detect WNV RNA in the absence of infectious viral particles might be because (1) the virus titer in the overwintering mosquito may be near or below the detectable limits of the plaque assay method; (2) the virus may be noninfectious because of biologic changes in overwintering mosquitoes; (3) the virus may have been killed during the collection and processing of specimens; (4) noninfectious viral RNA may persist in the mosquitoes; or (5) the results were false positives. Attempts to isolate virus from these pools are continuing using other isolation systems.

It is unknown whether WNV will persist in the New York area. Overwintering mosquitoes were difficult to locate, and intact WNV has not been identified. Three fourths of all specimens were obtained from the Fort Totten site. Surveillance of overwintering mosquitoes will continue.

WNV can be transmitted from parent to offspring mosquitoes,5 and this vertical transmission has been documented in field populations of Culex univittatus in Kenya.6 The role of vertical transmission in the maintenance cycles of this virus is uncertain. A related flavivirus (St Louis encephalitis virus) may persist through the winter in vertically infected, diapausing Culex mosquitoes, but it is probably a rare occurrence if it occurs in nature.7

The findings in this report demonstrate the value of continued vigilance in detecting the re-emergence of WNV. Counties where WNV transmission occurred in 1999 should monitor closely for WNV and conduct mosquito-control activities in the spring to reduce the potential for recurrence and amplification of WNV. Mosquito-control activities include reducing the number of mosquito breeding sites, particularly around homes and suburban and urban areas, and applying larvicide to Culex larval habitats early.

In December 1999, CDC announced availability of funds to suppot WNV surveillance, prevention, and control programs. The 19 state and local health departments eligible to apply for these funds represent areas where WNV transmission already has occurred or where transmission would be more likely to occur based on bird migration patterns. The focus of these cooperative agreements enables state and local health departments to increase surveillance activities and enhance laboratory capacity for detecting WNV and other arboviruses. In 2000, surveillance activities will be focused on determining whether WNV survived the winter and, if so, to ascertain its geographic distribution along the Atlantic and Gulf coasts.


References: 7 available
*The use of trade names is for identification only and does not imply endorsement by CDC or the US Department of Health and Human Services.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles